SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Bitcoins selloff amid concerns over a reported Binance security breach is weighing on Strategy shares, with traders debating whether the crypto-market shock signals deeper trouble or a buying opportunity. Concerns about Strategys quarterly results and CFO transition add to the bearish discussion, while some investors expect a rebound.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

DaVitas warning that DefenCath reimbursement could decline after the TDAPA transition has fueled a sharp selloff and concerns about pricing and revenue. Traders disagree over the impact: some see a lasting commercial headwind, while others argue DaVitas outlook is preliminary and may overstate the risk; frustration with managements communication is also prominent.

Whirlpool Corp. engages in the manufacturing and marketing of home appliances. Its products include home laundry appliances, refrigerators and freezers, cooking appliances, home dishwashers, and room air-conditioning equipment, mixers, and portable household appliances. The firm's brands include Whirlpool, KitchenAid, Maytag, Consul, Brastemp, Amana, Bauknecht, JennAir, and Indesit. It operates through the following geographical segments: Major Domestic Appliances (MDA) North America, Major Domestic Appliances (MDA) Latin America, Small Domestic Appliances (SDA) Global, and Others. The company was founded by Emory Upton, Fred Upton, and Louis C. Upton on November 11, 1911 and is headquartered in Benton Harbor, MI.

Whirlpool Corp.

Whirlpools weak Q1 results, sharply reduced full-year outlook and dividend suspension have driven attention, as the company cited recession-level appliance demand and blamed the Iran war and collapsing consumer confidence. Many traders are alarmed by the worsening outlook and debt burden, while some see the selloff as an overreaction and are buying for a possible rebound.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TGTX has reached fresh 52-week highs, with traders focused on an expected Q3 earnings report and debating whether the rally reflects BRIUMVI growth expectations or speculative buyout hopes and short covering. The buyout talk remains unconfirmed, and the earnings date has not been officially confirmed.

Corvus Pharmaceuticals, Inc. engages in the development of product candidates for the treatment of cancer and immune-mediated and inflammatory diseases. Its product candidates include soquelitinib, an ITK inhibitor, ciforadenant, an adenosine A2A receptor antagonist, and mupadolimab, a B cell-activating anti-CD73 antibody. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Traders are focused on a possible update on Corvuss ALPS program around the ASH abstract release and a company call, though the timing and whether the data will be disclosed remain uncertain. Optimism about a potential catalyst is countered by concerns over past delays, managements limited updates and heavy short interest.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

Weaker 2027 Medicare Advantage star ratings for Aetna are driving concern about lost bonus payments and future margin pressure. Traders are comparing CVSs weakness with Humanas rally on improved ratings, while debating whether the setback is already priced in.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

RASONQUE (daraxonrasib), Revolution Medicines pancreatic cancer therapy, remains the main focus: traders cite its Phase 3 survival results and FDA approval as support for the companys commercial and broader RAS-drug pipeline prospects. Discussion is also divided over valuation and efficacy across KRAS subtypes, with some traders pointing to competition from selective G12D drugs such as Verastems VS-7375.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovances updated NSCLC trial results and shift toward biomarker-selected lung-cancer studies are driving attention: the overall response rate was 24.6%, while a retrospective subgroup showed a stronger signal, but the lung-cancer filing is expected in 2027 and durability remains uncertain. Traders are divided between viewing the selloff as an overreaction to promising precision-treatment data and seeing a narrower, delayed opportunity compounded by managements confusing presentation.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apples fiscal fourth-quarter earnings report is the focus, with traders debating whether its premium valuation can be justified amid memory-cost pressures and concerns about iPhone demand and upgrade cycles. Some expect a sharp post-report drop, while others view Apples restrained AI spending and relative resilience during the tech selloff as supporting its safe-haven appeal.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

Fubos steep, low-volume decline and repeated new lows dominate the discussion, with many traders saying the selloff lacks a clear company-specific trigger. The community is looking to upcoming earnings and CEO Alisa Bowens strategic plan for clarity, while bears expect further downside and bulls argue for a turnaround or short-covering rebound.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

La Rosa Expands AI Push With NVIDIA B300 GPU Acquisition

LRHC expands its AI infrastructure push with NVIDIA B300 GPUs, long-term lease cash flows and a potential real estate divestiture.

La Rosa Stock Falls as Q2 Operating Loss Narrows, Revenues Drop Y/Y

LRHC's Q2 revenues fall y/y, but lower costs narrow its operating loss and lift the gross margin, while residential brokerage weakness weighs on the results.

La Rosa Q1 Loss Narrows Y/Y as Gross Profit Rises, Revenues Slip

LRHC's Q1 revenues decline y/y, but gross profit rises 29.6% and the operating loss narrows 46.5% as commercial brokerage growth and cost controls offset market weakness.

La Rosa Loss Widens Y/Y in 2025 Despite 17% Revenue Growth

LRHC reports 17% y/y revenue growth in 2025, but widening losses, internal control issues and a proposed AI infrastructure acquisition weigh on sentiment.

Why Is La Rosa Stock Sinking On Thursday?

La Rosa Holdings (NASDAQ: LRHC) faces a 20% sell-off following a Nasdaq non-compliance notice. Learn why it missed its filing deadline.read more...

La Rosa Launches My Agent Account 5.0 for Smarter Transactions

LRHC is set to launch My Agent Account 5.0, an AI-driven platform upgrade designed to streamline transactions, boost efficiency and enhance client engagement across its growing network.

Are NATH, LRHC, NFBK, CLBK Obtaining Fair Deals for their Shareholders?

Are NATH, LRHC, NFBK, CLBK Obtaining Fair Deals for their Shareholders? Are NATH, LRHC, NFBK, CLBK Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, March 9, 2026 Insiders may stand...

LRHC Stock Alert: Halper Sadeh LLC is Investigating Whether La Rosa Holdings Corp. is Obtaining a Fair Deal for its Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the merger of La Rosa Holdings Corp. (NASDAQ: LRHC) and Consensus Core Technologies, Inc. Upon completion of the proposed transaction...

A Real Estate Firm Has Made An AI Infrastructure Play – And Its Stock Is Surging

Equity

The company announced the acquisition of a minority stake in an AI-infrastructure company in an all-stock deal.

Biotech Surge Meets Defense and AI Momentum

Today’s market fireworks is powered by fresh capital for pipeline advancement, while defense tech and AI infrastructure plays ride waves of strategic mergers, partnerships, and funding commitments. These developments underscore investor enthusiasm for high-growth areas like sustainable biomaterials, obesity treatments, autonomous systems, and AI compute capacity, sectors increasingly tied to national priorities and technological edge. $KBLB, $RLMD, $HIMS, $NVO, $AGH, $LRHC, $AZI

Stratum Holdings Corp. operates as a holding company, which provides real estate brokerage services. It sells technology-based products and services primarily to sales agents and the sales agents associated with its franchisees. The company operates through the five reportable segments: Residential Real Estate Brokerage Services, Franchising Services, Coaching Services, Property Management, and Commercial Real Estate Brokerage Services. The Residential Real Estate Brokerage Services segment engages in the real estate brokerage business. The Franchising Services segment engages in the franchising of real estate brokerage agencies. The Coaching Services segment engages in the delivery of coaching services to its brokers and franchisee's brokers. The Property Management segment engages in the training of its sales agents to provide residential property management services to owners of single family residential properties. The Commercial Real Estate Brokerage Services segment engages in the brokering of the sale of commercial real estate. The company was founded by Joseph La Rosa in 2004 and is headquartered in Celebration, FL.

La Rosa Holdings Corp

Neutral Sentiment

<ul class="summary-bullets"><li>If completed, current La Rosa shareholders would own about 3.1% of the combined company.</li><li>Consensus develops high-performance data centers and GPU cloud platforms across the U.S. and Canada.</li><li>Consensus will appoint the post-transaction CEO and chairman.</li></ul>Shares of La Rosa Holdings Corp (LRHC) surged more than 25% on Monday after the company made its foray into the AI infrastructure market with the acquisition of a minority stake in Consensus Core Technologies.La Rosa signed a non-binding letter of intent to acquire Consensus, a provider of infrastructure for artificial intelligence and high-performance computing, in an all-stock deal, with no cash consideration.If completed, current La Rosa shareholders would own about 3.1% of the combined company, while Consensus equity holders would control the remaining 96.9%. Consensus will also appoint the post-transaction CEO and chairman.Consensus develops high-performance data centers and GPU cloud platforms across the U.S. and Canada."The global demand for AI computing infrastructure is expanding at an extraordinary pace, and we believe Consensus is well positioned to play an important role in meeting that demand. Combined with significant power capacity and its partnership with NVIDIA, in our view, Consensus is well positioned to build the scalable infrastructure needed to support the next wave of AI workloads," said Joe La Rosa, CEO of La Rosa Holdings Corp."This opportunity aligns with our strategy of identifying high-growth platforms where we can combine operational expertise with access to the public markets to accelerate expansion and create long-term shareholder value."<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits for <a href="https://stocktwits.com/symbol/LRHC">LRHC</a> flipped to "bullish" from "bearish" a day earlier, amid "high" message volumes.<img src="https://news.stocktwits-cdn.com/LRHC_jpg_c626938689.webp" alt="LRHC.jpg">One user said that the setup can surprise.<stembedurl>https://stocktwits.com/finwire99/message/647020256</stembedurl>One user expects a breakout beyond $1.25.<stembedurl>https://stocktwits.com/Romeo888/message/647011216</stembedurl>Read also: <a href="https://stocktwits.com/news-articles/markets/equity/uniqure-qure-stock-jumps-fda-huntington-disease-brokerage-upgrade/cZdV8lsRIIF">QURE Jumps 20% – Analysts Upgrade Stock On Huntington’s Disease&nbsp;Therapy Update, Retail Eyes $150</a>&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

A computer with the acronym AI for Artificial Intelligence, on 24 October, 2025 in Barcelona, Catalonia, Spain.

Why Did LRHC Stock Soar 25% Today?

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$0.172
Prev Close	$0.1963
Open	$0.186
Dividend Yield	0.00%
50-Day Moving Average	$1.92
Beta	1.19
Avg. Volume	174,972.53
PE Ratio	0.00

52-Week High	$3,342.00
52-Week Low	$0.1522
Market Capitalization	$111,859.00
EPS (Annual)	-$21,183.19
Price to Book	-0.01
Revenue Per Employee	$1.59M

Feed

News

Sentiment

Fundamentals

Info

LRHC Fundamentals